Michel Garneau
Boehringer Ingelheim (Germany)(DE)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Hepatitis C virus research, HIV Research and Treatment, Metabolism and Genetic Disorders, Diet and metabolism studies
Most-Cited Works
- → Structure−Activity Study on a Novel Series of Macrocyclic Inhibitors of the Hepatitis C Virus NS3 Protease Leading to the Discovery of BILN 2061(2004)186 cited
- → Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1(2014)176 cited
- → A potent peptidomimetic inhibitor of HSV ribonucleotide reductase with antiviral activity in vivo(1994)132 cited
- → Preclinical Characterization of BI 201335, a C-Terminal Carboxylic Acid Inhibitor of the Hepatitis C Virus NS3-NS4A Protease(2010)109 cited
- → Preclinical Profile of BI 224436, a Novel HIV-1 Non-Catalytic-Site Integrase Inhibitor(2014)98 cited
- → Human Intestinal Transporter Database: QSAR Modeling and Virtual Profiling of Drug Uptake, Efflux and Interactions(2012)92 cited